National Health Investors (NHI) Cash from Financing Activities (2009 - 2026)

National Health Investors' Cash from Financing Activities history runs 18 years deep, the most recent figure standing at $55.8 million for Q1 2026.

• Quarterly Cash from Financing Activities fell 60.1% year-over-year to $55.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$58.3 million (down 135.95% YoY) and the FY2025 annual result came in at $25.7 million, up 289.48% from the prior year.
• Cash from Financing Activities was $55.8 million for Q1 2026 at National Health Investors, down from $57.3 million in the prior quarter.
• Across five years, Cash from Financing Activities topped out at $139.8 million in Q1 2025 and bottomed at -$244.9 million in Q2 2022.
• A 5-year average of -$29.6 million and a median of -$36.2 million in 2022 frame the typical range for Cash from Financing Activities.
• Annual changes were most pronounced in 2023 — Cash from Financing Activities slumped 571.7% — and 2025, when it surged 489.08%.
• National Health Investors' Cash from Financing Activities stood at -$7.4 million in 2022, then slumped by 571.7% to -$49.4 million in 2023, then surged by 327.37% to $112.4 million in 2024, then slumped by 49.01% to $57.3 million in 2025, then retreated by 2.66% to $55.8 million in 2026.
• Business Quant data shows NHI's Cash from Financing Activities at $55.8 million in Q1 2026, $57.3 million in Q4 2025, and -$41.9 million in Q3 2025.